Try our beta test site
97 studies found for:    HSV-2
Show Display Options
Rank Status Study
1 Recruiting Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine
Condition: Herpes Genitalis
Interventions: Biological: VCL-HB01;   Other: Phosphate-buffered saline
2 Active, not recruiting Evaluating New Formulation of Therapeutic HSV-2 Vaccine
Condition: Genital Herpes Simplex Type 2
Interventions: Biological: Matrix-M2;   Biological: GEN-003;   Drug: Placebo
3 Completed HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.
Conditions: HIV Infection;   Herpes Simplex;   Sexually Transmitted Diseases
Interventions: Drug: valacyclovir;   Drug: matching placebo
4 Completed HSV-2 Shedding Resolution After Acyclovir Treatment
Condition: Genital Herpes
Intervention: Drug: acyclovir
5 Completed Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon
Conditions: HIV-1 and HSV-2 Coinfection;   HIV Infections
Intervention: Drug: Acyclovir
6 Completed Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2
Condition: HSV-2
Intervention: Biological: pPJV7630 administered by PMED
7 Active, not recruiting Effect of HSV-2 Suppressive Therapy on Sexual Behavior
Condition: Genital Herpes
Intervention: Drug: acyclovir
8 Completed HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons
Conditions: HIV Infections;   Herpes Simplex;   Sexually Transmitted Diseases
Interventions: Drug: Valacyclovir;   Drug: Matching Placebo
9 Withdrawn Valacyclovir Suppression to Improve the Stability of Vaginal Flora Among HSV-2 Seropositive Women
Conditions: Bacterial Vaginosis;   Herpes Simplex Virus Type II
Interventions: Drug: Placebo;   Drug: Valacyclovir
10 Completed Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine
Condition: Genital Herpes Simplex Type 2
Interventions: Biological: Matrix-M2 Adjuvant;   Biological: GEN-003 Vaccine;   Drug: Placebo
11 Completed Seroprevalence of HSV-2 in HIV Infected Subjects and the Effect of Daily Valacyclovir in the Reduction of HSV-2 Recurrence and Viral Shedding
Conditions: HSV-2;   HIV;   HIV Infections
Interventions: Drug: Valacyclovir;   Drug: Placebo
12 Active, not recruiting HSV529 Vaccine in HSV-2 Seropositive Adults
Condition: Herpes Simplex Virus 2
Interventions: Biological: HSV529;   Drug: Valacyclovir
13 Completed A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients
Conditions: Genital Herpes;   Herpes Genitalis
Intervention: Drug: valaciclovir (Valtrex)
14 Completed A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects
Condition: HSV-2
Intervention: Biological: pPJV7630 with pPJV2012 administered by PMED
15 Completed
Has Results
HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding
Conditions: HIV Infections;   Herpes Simplex
Interventions: Drug: valacyclovir;   Drug: placebo
16 Completed
Has Results
Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV
Conditions: Genital Herpes;   HIV Infection
Interventions: Drug: valacyclovir;   Drug: acyclovir
17 Completed
Has Results
Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)
Condition: Chronic Hepatitis C Infection
Interventions: Drug: Valacyclovir;   Drug: Placebo
18 Unknown  A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation
Condition: Genital Herpes
Intervention: Drug: acyclovir
19 Completed A Randomized Controlled Trial of Acyclovir Among HIV and HSV-2 Co-Infected Women, Chiang Rai, Thailand
Conditions: HIV;   Herpes
Intervention: Drug: acyclovir
20 Completed VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.
Condition: Infections, Herpesviridae
Intervention: Drug: Valaciclovir

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.